Lv1
20 积分 2025-04-03 加入
Gut microbiota and metabolites as predictors of biologics response in inflammatory bowel disease: A comprehensive systematic review
15小时前
已完结
Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial
17小时前
已完结
皖公网安备34019202002308
